Directory Organotropona funds The governing bodies of the urinary and reproduction Dioretiki Vero-spironolakton
This page is translated automatically with a help of Google Translate

Vero-spironolakton

See also Spironolactone

Roman name

Vero-spironolacton

The composition and the form of

1 tablet contains spironolakton 0,025 g; in a contour acheikova packing 10 pcs. , in a cardboard bundle two packaging.

Of drugs

Dioreticescoe. Is competitive aldosterone antagonist, improves the ions Na ^ + (natriyureticescoe effect), reduced-K ^ +, and urea (in distalnom nefrona Division), titruemuyu reduces acidity of urine. Do diurez (natriyureticescoe effect), and lowers AD. Warn adverse impact on the concentration of tissue and organs (slows development fibrosis attack endotelia dysfunction, etc.).

Indications

Giperaldosteronizm, incl. diagnostics, gipokaliemia, arterial hypertension, otechny syndrome, female heart failure, cirrhosis.

Pregnancy and lactation

Contraindicated. At the time of treatment should stop breastfeeding.

Contraindications

Major functions of the kidneys, acute renal failure, anuria, giperkaliemia, pregnancy (especially I trimester), breast-feeding.

Side-Effects

For part of the intestine : neuralgia, pain in the abdomen, Diarea.so the nervous system and sensory organs : headache, drowsiness, and mental disorders, Ataccia.so the urogenital system : dismenorea, metrorragia menopausal violation sexual Funktion.prochie : ginekomastia, girsutizm, brutalization vote, fever, urticaria.

Patient interaction

Do effect etc. dioretikov and gipotenziveh drugs.

Dosing and Administration

Inside, after delivery, in one or more receptions. The swelling in the face of chronic heart failure, the initial dose of 111 g / day with a maximum of 0.1 g / day; In the head in the face of cirrhosis 0.1-0.4 g / day (depending on the ratio of potassium and sodium in the blood plasma). Supporting dose is determined individually. The swelling in the face nefroticski syndrome 0.1-0.2 g / Sut.pri treating hypertension essencialna adults on 0.05-0.1 g / day; Where appropriate daily dose gradually over two weeks, increasing to 0.2 g / sut. Duration of treatment is not less than two weeks. Children appoint an average of 3 mg / kg / sut. Dosage selected on the basis of response and portable products. Multiple admission 1-2 times a Sutki.dla diagnosis and treatment of primary giperaldosteronizma 0.1-0.4 g / sut. Patients, who are not eligible for the operation, can be used as long-term maintenance therapy in minimal doses (fixed individually). To prevent gipokaliemii in treating saluretikami : 0,025-0,1 g / Sut.propuschennuu dose should be taken as soon as possible, but it should not be taken if prior to the next dose not have time. It is not possible to the double dose.

Storage conditions

table. : List B. In dry the dark spot

Shelf life

table. : 2 grams.

All products of this group

0